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Primitiveneuroectodermaltumor(PNET)isarare“smallroundbluecell tumor”thatisdiagnosedby openbiopsyorpercutaneous
biopsyofthelesionunder radiologicguidance.Inthiscasereport, we presentanovelapproachtothediagnosisofaretroperitoneal
PNET by endoscopic ultrasound- (EUS-) guided ﬁne needle aspiration (FNA). A 35-year-old man presented with the history of
left-sidedﬂankpainandswelling of3-weeks duration.Computerized tomography(CT)scanofhisabdomenrevealed a12.8×13×
12.5cm cystic and solidmassarisingfrom the retroperitoneum and displacing the third and fourth portions ofthe duodenum. He
underwent EUS which revealed a well-circumscribed heterogeneous mass abutting the inferior portion of the stomach. EUS-FNA
ofthemassrevealed malignantcells consistentwithprimitiveneuroectodermal tumor(PNET)/Ewing’ssarcoma.EUS-guided FNA
is an appropriate technique for diagnosing retroperitoneal PNET/Ewing’s sarcoma.
1.Introduction
Endoscopic ultrasound- (EUS-) guided ﬁne needle aspira-
tion (FNA) is a widely used diagnostic method for obtaining
tissue samples from lesions within the gastrointestinal (GI)
tractandinselectextra-GI conditionssuchasforsamplingof
hilar tumors, mediastinal lymph nodes, gallbladder lesions,
pancreatic lesions, and kidney/adrenal masses. Primitive
neuroectodermal tumor (PNET) is a rare “small round blue
celltumor”thatbelongstothefamily ofEwing’ssarcoma [1].
D i a g n o s i so ft h i sc o n d i t i o ni sroutinely based on obtaining
pathological samples by open biopsy or core biopsy and,
recently, the FNA technique. We report a case wherein a
retroperitoneal PNETwas diagnosedafterbiopsyusing EUS-
guided FNA.
2.CasePresentation
A 35-year-old man of middle-eastern origin presented with
leftﬂankpain for3weeks. Hehad nosigniﬁcant pastmedical
or surgical history. Review of systems was signiﬁcant for
change in bowel habits (constipation), weight loss (12lbs
in one month), and early satiety. Physical examination
revealed large palpable, nontender left abdominal mass.
Laboratories showed normocytic anemia with hemoglobin
of 12.2g/dL and mildly elevated level of alpha-fetoprotein
(14.6ng/ml). Computerized tomography (CT)-scan of the
abdomen revealed a 12.8 × 13 × 12.5cm cystic and solid
mass displacing the third and fourth portions of the duode-
num to the right (Figure 1(a)). EUS was performed which
revealed a large hypoechoic mass, with internal anechoic
areas and well-demarcated borders adjacent to the gastric
wall (Figure 1(b)). Maximum diameter of the mass on EUS
was 9.6 × 7.4cm, but the outer border of the mass was
beyond the limit of ultrasound penetration depth. EUS-FNA
was performed using a 22-gauge needle, and a total of 5
passes were performed. Bedside cytopathology conﬁrmed
adequacyofspecimen. Microscopicexamination ofcytologic
material revealeda cellularspecimen composedofnumerous








Figure 1: (a) CT ﬁlm showing large mass displacing small bowel to the right. The mass measured 12.8 × 13 × 12.5cm arising from the
retroperitoneum and was displacing the 3rd and 4th portions of the duodenum to the right. (b) EUS image of large hypoechoic mass
adjacent to the gastric wall, measuring 9.6 × 7.4cm. The distal aspect of the mass was beyond the reach of the ultrasound probe.
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Figure 2: Immunostains performed on cell block material displaying immunoreactivity of tumor cells with CD 99 (a), CD 117 (b), and
synaptophysin (c).
clusters. Individual tumor cells displayed enlarged hyper-
chromatic nucleiand a relativelyscant cytoplasm.Immunos-
taining of cell block material revealed immunoreactivity for
CD99 (Figure 2(a)), c-kit (Figure 2(b)), and synaptophysin
(Figure 2(c)). Immunoreactivities for leucocyte common
antigen, epithelial membrane antigen, pancytokeratin, and
chromogranin were all negative in tumor cells. The com-
bined cytomorphology and immunophenotype were consis-
tent with a peripheral neuroectodermal tumor/Ewing’s sar-
coma. Further imaging with positron emission tomography
(PET)revealedno evidenceofmetastatic disease.The patient
was started on neoadjuvant chemotherapy with a 5-drug
regimen: Vincristine, Adriamycin, Cytoxan, Ifosfamide, and
Etoposide. Repeat CT scan six weeks after chemotherapy
revealed shrinking of the lesion to a size of 8.4 × 7.3
× 9.0cm with central necrosis. He underwent exploratory
laparotomy with complete excision of retroperitoneal tumor.
The diagnosis of PNET/Ewing’s sarcoma was subsequently
conﬁrmed by histopathology of the excised tumor.
3.Discussion
Ewing’s tumor arises from long bones and soft tissue. When
Ewing’stumorarises from soft tissues, it iscalled “extraskele-
tal Ewing’s tumor” (EES). PNET, similar to Ewing’s tumor is
a round cell tumor originating from neuroectodermal crest.
Histologically, EES and PNET are closely related tumors
and have been grouped together as Ewing family of tumors
[1]. Patients with abdominal/retroperitoneal PNET present
with nonspeciﬁc symptoms like pain and a palpable mass
on examination. Diagnosis is routinely based on imaging
studies; however, biopsy is essential for deﬁnitive diagnosis.
The most commonly utilized biopsy techniques are either
open biopsy or an imaging-guided core biopsy. FNA has not
classically been used due to smaller tissue sample and lack of
tissue architecture. However, several studies have established
the usefulness of FNA in providing accurate diagnosis
through the new technology of immunocytochemistry, DNA
ﬂow cytometry and molecular genetic studies [2–4].
As reported in this case, large tumors frequently need
to undergo neoadjuvant chemotherapy for tumor shrinkage
and thereby better surgical resection. Therefore, obtain-
ing precise diagnosis is fundamental for initiating proper
chemotherapeutic regime. Furthermore, the use of mini-
mally invasive technique in the diagnosis is preferred as it
minimizes the procedure-related risk and danger of malig-
nant cell dissemination during percutaneous biopsy. The
reported incidence of needle tract seeding ranges between
0.003% and 0.009% [5]. Tumor seeding of EUS-FNA tract
has been sparsely reported in the literature [6, 7], andDiagnostic and Therapeutic Endoscopy 3
substantial evidence for this complication is still lacking.
Notably, the risk of peritoneal spread of tumor cells is much
lower with EUS-FNA compared to percutaneous FNA [8].
Retroperitoneal PNET is uncommon, and evidence for
preferred diagnostic modalities for these lesions is not estab-
lished. However, based on the available evidence and clinical
reasoning, EUS-guided FNA appears a preferable approach
to diagnose retroperitoneal tumors including PNET. The
location of the tumor may further be a factor in determining
the preferred diagnostic approach. If the tumor is in the
proximity of the GI tract, EUS-guided FNA may be a
preferred approach.
EUS-guided FNA is an established method of obtaining
tissue samples for diagnosis of lesions within the GI tract as
well as outside. [9]. To the best of our knowledge, this would
be the ﬁrst detailed documentation providing evidence for
diagnosing retroperitoneal PNET using EUS-guided FNA
[10]. Our case demonstrates that EUS-guided FNA is an
emerging modality with potential to diagnose several lesions
outside of the GI tract.
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